This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Acquisition Of Rochester Medical Corporation By C. R. Bard, Inc. May Not Be In The Best Interests Of Rochester Medical Corporation Shareholders

SAN DIEGO and STEWARTVILLE, Minn., Sept. 5, 2013 /PRNewswire/ --  Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Rochester Medical Corporation (NASDAQ: ROCM) ("Rochester Medical") by C. R. Bard, Inc. (NYSE: BCR) ("Bard"). On September 4, 2013, Rochester Medical announced a definitive merger agreement under which Bard will acquire Rochester Medical for $20 in cash for each share of stock.  The transaction is expected to close in the fourth quarter of 2013.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36754LOGO)

Is the Merger Best for Rochester Medical and Its Shareholders?

Robbins Arroyo LLP's investigation focuses on whether the board of directors at Rochester Medical is undertaking a fair process to obtain maximum value and adequately compensate its shareholders in the merger.  On July 30, 2013, Rochester Medical issues a press release announcing the company's operating results for its third quarter ended June 30, 2013, reporting strong increases in net income and sales.  Specifically, Rochester Medical reported a 127% increase in net income to $1,130,000 as compared to $496,000 for the same period 2012.  The company also reported an increase in sales of approximately 10%, resulting from a 12% increase in Rochester Medical Direct Sales and a 5% increase in Private Label Sales.  In announcing these results, Rochester Medical's Chief Executive Officer and President Anthony J. Conway commented, "We reported another quarter of strong growth, led by the United States and the United Kingdom, where Direct Sales, excluding Foley Catheters, grew 30% and 26% respectively. We are pleased with our performance this year and remain on track to achieve our Foley adjusted 2013 guidance for revenue of approximately $67 million and after-tax profit of approximately $7 million."

Additionally, the officers and directors, who collectively own 11.2% of Rochester Medical's outstanding shares, have agreed to vote their shares in favor of the merger and also agreed to certain restrictions on the disposition of such shares.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,209.41 -79.22 -0.43%
S&P 500 2,105.65 -11.74 -0.55%
NASDAQ 4,977.1380 -30.9580 -0.62%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs